1016771

Esperanza Arce-Nunez — FEI 3012225696

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 5, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Miami, FL (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance